133 related articles for article (PubMed ID: 34882113)
1. Direct Acting Oral Anticoagulants Following Gastrointestinal Tract Surgery.
Hakeam HA; Alkhani M; Alyahya Z; Alawaji Z; Ofori S
J Cardiovasc Pharmacol; 2021 Dec; 78(6):867-874. PubMed ID: 34882113
[TBL] [Abstract][Full Text] [Related]
2. Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study.
Kreutz R; Persson PB; Kubitza D; Thelen K; Heitmeier S; Schwers S; Becka M; Hemmrich M
J Thromb Haemost; 2017 Oct; 15(10):2017-2028. PubMed ID: 28805299
[TBL] [Abstract][Full Text] [Related]
3. Interpatient Variation in Rivaroxaban and Apixaban Plasma Concentrations in Routine Care.
Gulilat M; Tang A; Gryn SE; Leong-Sit P; Skanes AC; Alfonsi JE; Dresser GK; Henderson SL; Rose RV; Lizotte DJ; Teft WA; Schwarz UI; Tirona RG; Kim RB
Can J Cardiol; 2017 Aug; 33(8):1036-1043. PubMed ID: 28754389
[TBL] [Abstract][Full Text] [Related]
4. Using a low-molecular weight heparin-calibrated anti-factor Xa assay to assess the concentration of apixaban and rivaroxaban.
von Horn H; Rasmusson A; Söderblom L; Malmström RE; Antovic J
Int J Lab Hematol; 2022 Feb; 44(1):163-167. PubMed ID: 34523813
[TBL] [Abstract][Full Text] [Related]
5. An assay to measure levels of factor Xa inhibitors in blood and plasma.
Kim PY; Di Giuseppantonio LR; Wu C; Douketis JD; Gross PL
J Thromb Haemost; 2019 Jul; 17(7):1153-1159. PubMed ID: 30985986
[TBL] [Abstract][Full Text] [Related]
6. Microdosed Cocktail of Three Oral Factor Xa Inhibitors to Evaluate Drug-Drug Interactions with Potential Perpetrator Drugs.
Mikus G; Foerster KI; Schaumaeker M; Lehmann ML; Burhenne J; Haefeli WE
Clin Pharmacokinet; 2019 Sep; 58(9):1155-1163. PubMed ID: 30828771
[TBL] [Abstract][Full Text] [Related]
7. DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register.
Cini M; Legnani C; Padrini R; Cosmi B; Dellanoce C; De Rosa G; Marcucci R; Pengo V; Poli D; Testa S; Palareti G
Int J Lab Hematol; 2020 Apr; 42(2):214-222. PubMed ID: 32039550
[TBL] [Abstract][Full Text] [Related]
8. Influence of direct oral anticoagulants on thrombin generation on Ceveron TGA.
Pfrepper C; Behrendt LC; Bönigk H; Siegemund T; Metze M; Franke D; Petros S; Siegemund A
Int J Lab Hematol; 2022 Feb; 44(1):193-201. PubMed ID: 34585540
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban and Apixaban Anti-Xa Measurements: Impact of Plasma Storage for 7 Days at Room Temperature.
Boissier E; Genebrier S; Lakhal K; Nedelec-Gac F; Trossaërt M; Ternisien C; Gouin-Thibault I
Thromb Haemost; 2018 Aug; 118(8):1488-1490. PubMed ID: 29960274
[No Abstract] [Full Text] [Related]
10. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants.
Testa S; Paoletti O; Legnani C; Dellanoce C; Antonucci E; Cosmi B; Pengo V; Poli D; Morandini R; Testa R; Tripodi A; Palareti G
J Thromb Haemost; 2018 May; 16(5):842-848. PubMed ID: 29532628
[TBL] [Abstract][Full Text] [Related]
11. Laboratory measurement of the direct oral anticoagulants: Indications and impact on management in clinical practice.
Wright C; Brown R; Cuker A
Int J Lab Hematol; 2017 May; 39 Suppl 1():31-36. PubMed ID: 28447413
[TBL] [Abstract][Full Text] [Related]
12. Retrospective study of clinical settings, indications and consequences of measurement of direct oral anticoagulant plasma levels in Northern Tasmania, Australia.
Lim MS; Mohamed M
Intern Med J; 2024 Jun; 54(6):932-940. PubMed ID: 38213182
[TBL] [Abstract][Full Text] [Related]
13. Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles.
Goto E; Horinaka S; Ishimitsu T; Kato T
Drug Metab Pharmacokinet; 2020 Feb; 35(1):151-159. PubMed ID: 32007354
[TBL] [Abstract][Full Text] [Related]
14. Direct oral anticoagulants and heparins: laboratory values and pitfalls in 'bridging therapy'.
Eller T; Flieder T; Fox V; Gripp T; Dittrich M; Kuhn J; Alban S; Knabbe C; Birschmann I
Eur J Cardiothorac Surg; 2017 Apr; 51(4):624-632. PubMed ID: 28043992
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants Plasma Levels in Patients with Atrial Fibrillation at the Time of Bleeding: A Pilot Prospective Study.
Škorňová I; Samoš M; Bolek T; Kamenišťáková A; Stančiaková L; Galajda P; Staško J; Kubisz P; Mokáň M
J Cardiovasc Pharmacol; 2021 Jul; 78(1):e122-e127. PubMed ID: 34173805
[TBL] [Abstract][Full Text] [Related]
16. Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).
Hakeam HA; Al-Sanea N
J Thromb Thrombolysis; 2017 Apr; 43(3):343-351. PubMed ID: 28050755
[TBL] [Abstract][Full Text] [Related]
17. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation.
Bendayan M; Mardigyan V; Williamson D; Chen-Tournoux A; Eintracht S; Rudski L; MacNamara E; Blostein M; Afilalo M; Afilalo J
J Am Geriatr Soc; 2021 Apr; 69(4):1012-1018. PubMed ID: 33432589
[TBL] [Abstract][Full Text] [Related]
18. Modified ROTEM for the detection of rivaroxaban and apixaban anticoagulant activity in whole blood: A diagnostic test study.
Pailleret C; Jourdi G; Siguret V; Gouin-Thibault I; Gandrille S; Stepanian A; Curis E; Golmard JL; Gaussem P; Le Bonniec B; Samama CM
Eur J Anaesthesiol; 2019 Jun; 36(6):449-456. PubMed ID: 30308522
[TBL] [Abstract][Full Text] [Related]
19. Exploring the effect of factor Xa inhibitors on rotational thromboelastometry: a case series of bleeding patients.
Mahamad S; Chaudhry H; Nisenbaum R; McFarlan A; Rizoli S; Ackery A; Sholzberg M
J Thromb Thrombolysis; 2019 Feb; 47(2):272-279. PubMed ID: 30506352
[TBL] [Abstract][Full Text] [Related]
20. Real-World Rivaroxaban and Apixaban Levels in Asian Patients With Atrial Fibrillation.
Lin SY; Kuo CH; Yeh SJ; Tsai LK; Liu YB; Huang CF; Tang SC; Jeng JS
Clin Pharmacol Ther; 2020 Jan; 107(1):278-286. PubMed ID: 31376150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
